HJ Science

HJ Science, established in 2017 with its headquarters in Wenjiang District, Chengdu, is a biopharmaceutical technology enterprise focused on the research and production of innovative small-molecule chemical drugs. The company is committed to the development of new drugs addressing significant clinical needs, with core products centered around next-generation tumor microenvironment therapies and treatments for complex metabolic diseases. The company has built a comprehensive drug development platform covering drug design and synthesis, screening and evaluation, quality analysis, pharmacology, efficacy, and formulation development.